Three months after DarioHealth launched its smartphone-connected glucometer in the US, the company reports more than 100 percent increase in growth, bringing in $669,000 in revenue in the second quarter for 2016.
The increase is understandable, considering the US is the largest market for blood glucose markets. Israel-based Dario (which has rebranded itself, after previously operating under the...
